tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BOLT Stock Latest News

Bolt Biotherapeutics provides update on co-development collaboration with Toray
The FlyBolt Biotherapeutics provides update on co-development collaboration with Toray
20d ago
BOLT
Bolt Biotherapeutics Announces Board Changes and Appointments
PremiumCompany Announcements
Bolt Biotherapeutics Announces Board Changes and Appointments
2M ago
8K
BOLT
Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look
PremiumCompany Announcements
Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look
4M ago
BOLT
Bolt Biotherapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Bolt Biotherapeutics Reports Q3 2024 Financial Results
4M ago
BOLT
Bolt Biotherapeutics reports Q3 EPS (40c), consensus (35c)
PremiumThe Fly
Bolt Biotherapeutics reports Q3 EPS (40c), consensus (35c)
4M ago
BOLT
Bolt Biotherapeutics presents updated preclinical data for BDC-4182
PremiumThe FlyBolt Biotherapeutics presents updated preclinical data for BDC-4182
4M ago
BOLT
Bolt Biotherapeutics Announces Board Reshuffle and New Appointment
Premium
Company Announcements
Bolt Biotherapeutics Announces Board Reshuffle and New Appointment
6M ago
8K
BOLT
Bolt Biotherapeutics names Brian O’Callaghan chairman
Premium
The Fly
Bolt Biotherapeutics names Brian O’Callaghan chairman
6M ago
BOLT
Bolt Biotherapeutics reports Q2 EPS (56c), consensus (48c)
PremiumThe Fly
Bolt Biotherapeutics reports Q2 EPS (56c), consensus (48c)
7M ago
BOLT
SunPower, Accenture downgraded: Wall Street’s top analyst calls
PremiumThe Fly
SunPower, Accenture downgraded: Wall Street’s top analyst calls
10M ago
PK
SE
Bolt Biotherapeutics downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Bolt Biotherapeutics downgraded to Hold from Buy at JonesResearch
10M ago
BOLT
Bolt Biotherapeutics ceases BDC-1001 development, cuts 50% of staff
PremiumThe Fly
Bolt Biotherapeutics ceases BDC-1001 development, cuts 50% of staff
10M ago
BOLT
Bolt Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyBolt Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
10M ago
BOLT
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
10M ago
BOLT
Guggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
Premium
The Fly
Guggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
10M ago
BOLT
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
10M ago
BOLT
Bolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Bolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
10M ago
BOLT
Bolt Biotherapeutics reports Q1 EPS (28c), consensus (51c)
PremiumThe Fly
Bolt Biotherapeutics reports Q1 EPS (28c), consensus (51c)
10M ago
BOLT
Bolt Biotherapeutics Realigns Operations and Leadership Team
PremiumCompany Announcements
Bolt Biotherapeutics Realigns Operations and Leadership Team
10M ago
8K
BOLT
Bolt Biotherapeutics reports Q4 EPS (47c), consensus (48c)
PremiumThe FlyBolt Biotherapeutics reports Q4 EPS (47c), consensus (48c)
12M ago
BOLT
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
Premium
The Fly
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
1y ago
BOLT
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
Premium
The Fly
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
1y ago
BOLT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >